Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Indivior Total Liabilities and Share Holders Equity 2012-2024 | INDV

Indivior total liabilities and share holders equity from 2012 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  
Indivior Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $1,954
2022 $1,769
2021 $1,832
2020 $1,531
2019 $1,652
2018 $1,547
2017 $1,444
2016 $1,209
2015 $937
2014 $747
2013 $426
2012 $557
2011 $559
Indivior Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $1,535
2024-03-31 $1,453
2023-12-31 $1,948
2023-09-30 $1,852
2023-06-30 $1,731
2023-03-31 $1,755
2022-12-31 $1,769
2022-09-30 $1,671
2022-06-30 $1,720
2022-03-31 $1,724
2021-12-31 $1,832
2021-09-30 $1,700
2021-06-30 $1,671
2021-03-31 $1,611
2020-12-31 $1,531
2020-09-30 $1,547
2020-06-30 $1,551
2020-03-31 $1,512
2019-12-31 $1,652
2019-09-30 $1,590
2019-06-30 $1,568
2019-03-31 $1,605
2018-12-31 $1,547
2018-09-30 $1,555
2018-06-30 $1,582
2018-03-31 $1,499
2017-12-31 $1,444
2017-09-30 $1,367
2017-06-30 $1,329
2017-03-31 $1,225
2016-12-31 $1,209
2016-09-30 $1,089
2016-06-30 $1,073
2016-03-31 $1,023
2015-12-31 $937
2015-09-30 $978
2015-06-30 $958
2015-03-31 $0
2014-12-31
2014-09-30 $0
2014-06-30 $0
2013-12-31 $426
2012-12-31 $557
2011-12-31 $559
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.347B $1.093B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $89.015B 35.47
Takeda Pharmaceutical (TAK) Japan $47.155B 9.44
Merck (MKGAF) Germany $23.651B 25.81
Astellas Pharma (ALPMY) Japan $22.060B 26.50
Summit Therapeutics (SMMT) United States $17.795B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.649B 0.00
United Therapeutics (UTHR) United States $15.242B 15.74
Shionogi (SGIOY) Japan $13.107B 12.56
Neurocrine Biosciences (NBIX) United States $12.102B 36.21
Catalent (CTLT) United States $10.946B 0.00
Orion OYJ (ORINY) Finland $7.423B 30.23
Revolution Medicines (RVMD) United States $7.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.766B 7.18
Ionis Pharmaceuticals (IONS) United States $6.194B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.063B 0.00
Corcept Therapeutics (CORT) United States $4.417B 37.41
Crinetics Pharmaceuticals (CRNX) United States $4.223B 0.00
Dyne Therapeutics (DYN) United States $3.448B 0.00
PTC Therapeutics (PTCT) United States $2.729B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.696B 15.55
Arrowhead Pharmaceuticals (ARWR) United States $2.583B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.425B 19.27
Soleno Therapeutics (SLNO) United States $2.082B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.942B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.780B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.647B 0.00
Xencor (XNCR) United States $1.625B 0.00
Harrow (HROW) United States $1.608B 0.00
Cassava Sciences (SAVA) United States $1.455B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.436B 0.00
Ocular Therapeutix (OCUL) United States $1.411B 0.00
Ardelyx (ARDX) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.314B 0.00
Evotec AG (EVO) Germany $1.290B 0.00
Collegium Pharmaceutical (COLL) United States $1.249B 7.17
Calliditas Therapeutics AB (CALT) Sweden $1.200B 0.00
Enliven Therapeutics (ELVN) United States $1.028B 0.00
Relay Therapeutics (RLAY) United States $1.015B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.013B 0.00
Bioventus (BVS) United States $0.947B 30.76
4D Molecular Therapeutics (FDMT) United States $0.874B 0.00
Cronos Group (CRON) Canada $0.868B 0.00
USANA Health Sciences (USNA) United States $0.759B 13.92
Savara (SVRA) United States $0.731B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.722B 45.20
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.676B 6.40
Exscientia (EXAI) United Kingdom $0.631B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.594B 0.00
Siga Technologies (SIGA) United States $0.569B 6.81
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
OmniAb (OABI) United States $0.545B 0.00
Tourmaline Bio (TRML) United States $0.538B 0.00
Eliem Therapeutics (ELYM) United States $0.535B 0.00
Foghorn Therapeutics (FHTX) United States $0.529B 0.00
Altimmune (ALT) United States $0.528B 0.00
Verve Therapeutics (VERV) United States $0.466B 0.00
Sage Therapeutics (SAGE) United States $0.463B 0.00
KalVista Pharmaceuticals (KALV) United States $0.462B 0.00
Aquestive Therapeutics (AQST) United States $0.451B 0.00
Larimar Therapeutics (LRMR) United States $0.437B 0.00
Xeris Biopharma Holdings (XERS) United States $0.432B 0.00
Elite Pharmaceuticals (ELTP) United States $0.414B 38.75
Zevra Therapeutics (ZVRA) United States $0.412B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Aldeyra Therapeutics (ALDX) United States $0.349B 0.00
Lyell Immunopharma (LYEL) United States $0.346B 0.00
Korro Bio (KRRO) United States $0.342B 0.00
Esperion Therapeutics (ESPR) United States $0.341B 0.00
Lexeo Therapeutics (LXEO) United States $0.317B 0.00
Heron Therapeutics (HRTX) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.284B 0.00
Avita Medical (RCEL) United States $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.251B 17.14
Enanta Pharmaceuticals (ENTA) United States $0.241B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.240B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Nanobiotix S.A (NBTX) France $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.232B 0.00
Pyxis Oncology (PYXS) United States $0.216B 0.00
CytoDyn (CYDY) United States $0.199B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.196B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
Context Therapeutics (CNTX) United States $0.147B 0.00
Century Therapeutics (IPSC) United States $0.140B 0.00
Prelude Therapeutics (PRLD) United States $0.134B 0.00
OptiNose (OPTN) United States $0.128B 0.00
Fractyl Health (GUTS) United States $0.128B 0.00
Assertio Holdings (ASRT) United States $0.124B 21.67
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Journey Medical (DERM) United States $0.106B 0.00
Regulus Therapeutics (RGLS) United States $0.106B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
CASI Pharmaceuticals (CASI) China $0.105B 0.00
Metagenomi (MGX) United States $0.100B 0.00
Citius Pharmaceuticals (CTXR) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.092B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Vivani Medical (VANI) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Inotiv (NOTV) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.047B 0.00
FibroGen (FGEN) United States $0.042B 0.00
DURECT (DRRX) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Protara Therapeutics (TARA) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Tempest Therapeutics (TPST) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.031B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
BioVie (BIVI) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Talphera (TLPH) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.015B 0.00
Indaptus Therapeutics (INDP) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.48
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.56